Explore more by category
Period
Filter by
recent search
Showing: 1 – 5 of 205 stories
02 February 2026 – 1 mins read
Ipsen Earns a Top Climate Rating: What is CDP, and Why Does It Matter?
Together for the Climate: Ipsen Strengthens Its Climate Commitment with CDP A-List Recognition and SBTi Approval
19 January 2026 – 1 mins read
Alagille syndrome (ALGS) Awareness Day – Where powerful connections can make the difference
“We were shocked” That is how Celine felt when her family received the news that her daughter Suzanne had been diagnosed with the rare liver disease, Alagille Syndrome (ALGS) at just a few months old.
14 January 2026 – 2 mins read
Closing Care Gaps in Post‑Stroke Spasticity
At Ipsen, our heritage in neuroscience has always been about more than advancing science – it is about transforming lives. Despite advances in care and numerous initiatives to prevent stroke, cases continue to rise over recent decades.
12 January 2026 – 2 mins read
Bridging science and leadership: Elisabetta Leo on guiding early development at Ipsen
Elisabetta Leo is moving science forward at the heart of early development. This involves progressing nonclinical data and novel molecules in oncology, from bench to bedside.
16 December 2025 – 2 mins read
Acquired Science. Accelerated Impact. Ipsen’s Determined M&A Strategy Is Rewriting the Rules of Innovation
Philippe Lopes-Fernandes, EVP & Chief Business Officer, shares how Ipsen’s tenacious approach to dealmaking is transforming breakthrough science into global impact—solidly.
